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Abstract
Background: To present an overview of the clinical negligence claims for ophthalmology in the
National Health Service (NHS) in England from 1995 to 2006. To compare ophthalmic
subspecialties with respect to claim numbers and payments.
Methods: All the claims on the NHS Litigation Authority database for ophthalmology for the
period 1995 to 2006 were analysed. Claims were categorised by ophthalmic subspecialty, and
subspecialties were ranked according to numbers of claims, total damages paid, average level of
damages and paid:closed ratio (a measure of the likelihood of a claim resulting in payment of
damages).
Results: There were 848 claims, 651 of which were closed. 46% of closed claims resulted in
payment of damages. The total cost of damages over the period was £11 million. The mean level
of damages was £37,100. Cataract made up the largest share of claims (31%), paediatric
ophthalmology had the highest mean damages (£170,000), and claims related to glaucoma were
most likely to result in payment of damages (64%).
Conclusion: Clinical negligence claims in ophthalmology in England are infrequent, but most
ophthalmologists will face at least one in their career. Ophthalmic subspecialties show marked
differences with regard to their litigation profiles. From a medical protection perspective, these
results suggest that indemnity premiums should be tailored according to the subspecialty areas an
ophthalmologist is involved in.
Background
Ophthalmic subspecialties differ significantly from each
other in terms of disease conditions, demographics, treat-
ments, and patient expectations. From a medicolegal per-
spective, this diversity means that ophthalmic
subspecialties should be considered separately, rather
than grouped together. Very little has been published in
the field of ophthalmic negligence, however, which aims
to compare and contrast between the clinically recognised
ophthalmic subspecialties.
An ideal data source which may be used to study ophthal-
mic subspecialty litigation is the claims database of the
National Health Service Litigation Authority (NHSLA).
The NHSLA handles all claims against National Health
Service (NHS) trusts in England [1]. Its database includes
claims from April 1995 onwards. From 1995 to 2002,
some trusts handled smaller claims by themselves, but the
NHSLA estimates that over 90% of claims in that period
reached the database (personal communication). Since
April 2002, the NHSLA handled every clinical negligence
claim in the NHS, and so the database from that date is
all-inclusive.
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gation in USA, data from a European perspective are gen-
erally lacking [2]. Previous UK studies which analysed
claims in the private sector represent a different spectrum
of practice from the mainstream NHS [3,4]. Studies which
have utilised NHSLA data for ophthalmology have been
confined to a single subspecialty [5,6]. Furthermore, there
are very few reports at all which seek to compare between
ophthalmic subspecialties. Those that did, have utilised
classifications that do not correspond to the ophthalmic
subspecialties found in clinical practice [7]. Drawing on
the NHSLA database, this study aims to provide a decade-
long overview of ophthalmology negligence claims in the
NHS in England, focusing on comparisons between the
standard ophthalmic subspecialties.
Methods
Data on ophthalmology-related claims in the NHS were
obtained by submitting an online data request form to the
NHSLA. Information was requested on all claims arising
from the specialty of ophthalmology from 1995 to 2006.
The anonymised, tabulated summary data provided by
the NHSLA were then analysed and claims were grouped
according to the following ophthalmic subspecialty divi-
sions: cataract, cornea (including external eye disease),
oculoplastics (including lacrimal and orbital), uveitis,
glaucoma, vitreo-retinal (VR) surgery, medical retina,
neuro-ophthalmology, strabismus, paediatric ophthal-
mology (paediatrics), oncology, and trauma. There was
also a miscellaneous category for claims where a subspe-
cialty could not be determined, as well as claims unrelated
to a subspecialty (eg falls in the department).
For the whole ophthalmology data set, and for each oph-
thalmic subspecialty, the number of ongoing claims
(open), completed claims (closed), and claims with pay-
ment of damages (paid) were determined. The total and
mean level of damages, as well as the paid:closed ratio
(which indicates the likelihood of a claim resulting in pay-
ment of damages) were calculated for each ophthalmic
subspecialty. Subspecialties were ranked according to
number of claims, total damages, mean level of damages
and paid:closed ratio.
In line with NHSLA guidance, the completed study was
submitted to a Risk Manager at the NHSLA for approval
and comments.
Results
The total number of claims from ophthalmology in the
NHS in England for the period April 1995 to August 2006
was 848. This implies a mean annual incidence of around
75 claims per year. Over the same period, the total
number of claims handled by the NHSLA for all special-
ties was 34,497, of which 13,449 were from surgical spe-
cialties [8]. Ophthalmology claims thus accounted for
around 2.5% of the total number of claims, and 6.3% of
the surgery claims over this period.
Of the 848 claims from ophthalmology, 651 were closed
and 197 remained open. Of the 651 closed claims, 299
resulted in payments, giving a paid:closed ratio of 46%.
The total damages for the 299 paid claims were £11.1 mil-
lion over the whole period, or £982,000 per year. The
mean damages for a paid claim was £37,100.
Numbers of claims
In Table 1, the ophthalmic subspecialties are ranked by
numbers of claims. Cataract accounts for nearly a third of
claim numbers, with retinal specialties (VR and medical
retina) comprising the next largest grouping.
Total damages
In Table 2, the ophthalmic subspecialties are ranked by
total damages. Five subspecialties (cataract, glaucoma,
medical retina, paediatrics and neuro-ophthalmology)
together account for 69% of the total damages for the spe-
cialty. The lowest ranking five specialties, however, (stra-
bismus, oncology, trauma, cornea and oculoplastics) are
responsible for only 8% of the total damages.
Mean level of damages paid
In Table 3, the ophthalmic subspecialties are ranked by
mean level of damages (in paid cases). Paediatric ophthal-
mology has a level of mean damages over twice that of any
other subspecialty. Cataract claims, though frequent, do
not result in high payments.
Paid:closed ratio
In Table 4, the ophthalmic subspecialties are ranked by
the paid:closed ratio, a measure of the likelihood of a
claim resulting in payment of damages. There is a more
Table 1: Ophthalmic subspecialties ranked by numbers of claims
Subspecialty Number of claims % of total
Cataract 264 31%
VR 81 10%
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than for claim numbers, total damages, or mean level of
damages.
Discussion
This study provides an overview of clinical negligence
claims in ophthalmology in England from 1995 to 2006
within the NHS. The main findings of this study can be
summarised as follows. In the context of NHS litigation as
a whole, ophthalmology accounts for only 2.5% of the
total number of clinical negligence claims. The total cost
to the NHS of damages for ophthalmology claims was £11
million in the last decade. Cataract accounts for nearly a
third of ophthalmology claims, with retinal subspecialties
making up nearly 20%. In terms of total damages paid,
however, cataract is only slightly greater than glaucoma,
medical retina, paediatrics and neuro-ophthalmology.
Paediatrics has the highest level of damages, over twice
that for every other subspecialty. Cataract damages,
although frequent, are less costly than the average for the
specialty. The likelihood of a claim resulting is payment of
damages is highest for glaucoma, followed by neuro-oph-
thalmology and oculoplastics.
The principal strength of the study is that the NHSLA data
are prospective and virtually comprehensive. This is
because all claims in the NHS in England are, as a matter
of procedure, handled by the NHSLA. The main limitation
of the data is the brevity of the case descriptions supplied,
which limits detailed analysis of causative factors for each
claim. This also accounts for a large proportion of the
claims which were classified in the miscellaneous cate-
gory. Further limitations are that the data do not include
claims from outside the NHS (ie private practice and gen-
eral practice), and are confined to England.
From a risk management perspective, it is important to
highlight that the negligence claims discussed in this
study represent just the tip of the risk iceberg. Near-
misses, undetected adverse outcomes, cases in which
patients do not take matters further, and resolution of
complaints by local or national non-legal bodies repre-
sent a large pool of clinical incidents, most of which never
reach the NHSLA.
Most of the reports about ophthalmic litigation in the lit-
erature come from USA. These include the publications of
large medical insurance groups such as the Ophthalmic
Mutual Insurance Company (OMIC) and the Physicians
Insurance Association of America (PIAA). The PIAA is an
association of over 50 medical malpractice insurance
companies, which between them insure over 60% of pri-
vate practitioners in USA. The PIAA's summary data of
claims for ophthalmology from 1985–2005 [9] provide a
useful point of comparison with the NHSLA data. The rel-
















Table 3: Ophthalmic subspecialties ranked by mean level of 
damages














Table 2: Ophthalmic subspecialties ranked by total damages
Subspecialty Total damages (£) % of total
Cataract 1.9 million 17%
Glaucoma 1.8 million 16%
Medical retina 1.6 million 14%
Paediatrics 1.4 million 12%
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is remarkably similar in England and USA (NHSLA: 2.5%
of total claims; PIAA: 2.9%). The average level of damages
awarded, though, is much higher in USA (PIAA:
$174,000; NHSLA: £37,100). The proportion of claims
resulting in payment (the paid:closed ratio), however, is
higher in England (NHSLA: 46%; PIAA 29%).
Comparisons of claims between ophthalmic subspecial-
ties in the literature are much less complete than the
present study, and have used categorisations more of
interest to insurers than to doctors [7]. Certain points of
agreement, however, can be realised. Due to its high vol-
ume, cataract is consistently found to be the largest single
contributor to claim numbers, accounting for 31% of the
NHSLA claims. Cataract accounted for 47% of the PIAA
claims and 29% of an older series from New Jersey [10].
In a personal review of 700 medicolegal cases, cataract
was the most frequent (22% of total) [7]. A recent review
of claims in the private sector in the UK also found cata-
ract to be the commonest reason for claims, making up
39% of the total [4]. The finding that paediatric ophthal-
mology claims result in the highest levels of payment is
corroborated by a study which examined only high-pay-
out cases in USA [11]. This reported that patients aged
under ten years had the largest monetary awards. The find-
ing that glaucoma has the highest paid:closed ratio (64%)
is confirmed by the PIAA data (42%). An area of ophthal-
mic practice conspicuously absent from the NHSLA data
is laser refractive surgery, which is scarcely performed in
the NHS. This is a major contributor to litigation in pri-
vate practice, however [2,4].
In 2005, there were 2,327 medical staff in ophthalmology
in England, of which 820 were consultants [12]. Using the
annual claim incidence reported above, and with certain
assumptions to permit estimation, the chance of an oph-
thalmologist of any grade being subjected to a claim in a
ten-year period is approximately 30%. The average doctor
in ophthalmology would therefore face one claim in a
thirty year career. For a consultant, there is a 90% chance
of having a claim in ten years arising from a patient under
his care, which equates to two claims in a twenty year
career as a consultant. Claims may be infrequent on a
national level, but the majority of ophthalmologists in
England will face at least one claim in their NHS career. Of
some comfort is the fact that most claims never reach the
courtroom, with 38% being abandoned by the claimant
and a further 43% settled out of court [8].
Conclusion
Clinical negligence claims in ophthalmology in England
are reassuringly infrequent, but most ophthalmologists
will face at least one in their career. Ophthalmic subspe-
cialties show marked differences with regard to their liti-
gation profiles. Cataract has the most claims, paediatric
ophthalmology the highest level of damages, and glau-
coma the highest rate of claim success. From a medical
protection perspective, these results suggest that indem-
nity premiums should be tailored according to the sub-
specialty areas an ophthalmologist is involved in.
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